Volume replacement strategies on intensive care units: results from a postal survey
Objective: To assess volume replacement strategies on intensive care units (ICUs) in Germany.
Design: A postal survey questionnaire of 18 questions was sent to 451 ICUs in Germany. The questionnaire was sent to general, surgical, anesthesiology, neurosurgery, cardiac surgery, and medical ICUs of hospitals with more than 200 beds.
Results: 286 questionnaires (64 % ) were returned and analysed. Hydroxyethylstarch (HES) solution is the solution most often used for volume replacement (total: 193 ICUs, exclusively HES: 93 ICUs), crystalloids are next (crystalloids exclusively: 61 ICUs), and human albumin is used rarely as a first choice. Clinical experience is a very important argument for administering volume. Diagnostic tools, e. g. measurement of central venous pressure or pulmonary capillary wedge pressure, also play an important role. Albumin/total protein and colloid osmotic pressure (COP) are measured often on ICUs (albumin measured routinely: 173 ICUs; COP measured routinely: 33 ICUs). Critical values for albumin/total protein are defined in most ICUs. Reduced plasma levels of albumin/total protein was the indication most often cited for administering human albumin. Only 149 ICUs (52%) have a financial budget for their unit. Costs still do not play a major role in the choice of volume replacement on 30 ICUs (10%).
Conclusions: The kind of volume therapy differs widely among the different ICUs. This questionnaire supported the supposition that no standards exist for volume therapy in intensive care patients. New results concerning the abuse of albumin in the critically ill have not yet influenced strategies of volume replacement.
Key wordsVolume replacement Colloids Crystalloids Intensive care unit Albumin Hydroxyethylstarch Gelatin Survey Critically ill Costs Questionnaire
Unable to display preview. Download preview PDF.
- 1.Sibbald WJ (1994) Fluid therapy in sepsis. In: Reinhart K, Eyrich K, Sprung C (eds) Sepsis — current perspectives in pathophysiology and therapy. (Update in intensive care and emergency medicine, vol 18) Springer, Berlin Heidelberg New York, pp 266–273Google Scholar
- 2.Thijs LG (1995) Fluid therapy in septic shock. In: Sibbald WJ, Vincent JL (eds) Clinical trials for the treatment of sepsis. (Update in intensive care and emergency medicine, vol 19) Springer, Berlin Heidelberg New York, pp 167–190Google Scholar
- 5.Davidson I (1989) Fluid resuscitation of shock: current controversies. Crit Care Med 17:1078–1080Google Scholar
- 7.Kapila A, Waldman CS, Uncles DR, Addy EV (1995) Survey of colloid usage in British intensive care units. Clin Intensive Care 6: A201Google Scholar
- 10.McClusky A, Thomas AN, Bowles BJ, Kishen R (1996) The prognostic value of serial measurement of serum albumin concentration in patients admitted to an intensive care unit. Anaesthesia 51: 724–727Google Scholar
- 17.Lucas CE, Ledgerwood AM, Higgins RF (1980) Impaired pulmonary function after albumin resuscitation from shock. J Trauma 20: 447–451Google Scholar
- 21.Schmand JF, Ayala A, Chaudry IH (1994) Influence of hydroxyethylstarch (HES) on inflammatory cytokine release following trauma and hemorrhagic shock. Intensive Care Med 20: 325Google Scholar